Drawing for BYPRUVIQ

USPTO serial 79265437

BYPRUVIQ

Reviewed by CopyMark Law Group

Reg. 5958408Status 709
Filing date
Status date
Registration date
Jan 14, 2020
Examiner
SETTLES LEWIS, SHAILA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BYPRUVIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use in the field of oncologySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 31, 2026C71TCANCELLED SECTION 71—
Mar 27, 2020GPNXNOTIFICATION PROCESSED BY IB—
Mar 7, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 6, 2020FIMPFINAL DISPOSITION PROCESSED—
Feb 13, 2020GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 14, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2019GPNXNOTIFICATION PROCESSED BY IB—
Oct 9, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 9, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 9, 2019NPUBNOTICE OF PUBLICATION—
Sep 21, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2019DOCKASSIGNED TO EXAMINER—
Sep 3, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 15, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance